Peptides patterned on the N-terminal sequence of fibronectin were synthesized and tested for amine acceptor qualities in reactions with dansylcadaverine catalyzed either by coagulation factor XIlla or intracellular transglutaminase (protein-glutamine:amine y-glutamyltransferase, EC 2.3.2.13). On the basis of inverse half-saturations of the enzymes, the order of acceptor substrate affinity for factor XIlla was pEAQQIV >> Boc-AQQIV > Boc-QQIV, and for transglutaminase, Boc-QQIV > Boc-AQQIV > pEAQQIV (amino acid residues are shown in one-letter code; pE, pyroglutamic acid; Boc, tert-butyloxycarbonyl). Sequence analysis of dansylcadaverine-substituted pEAQQIV indicated that the first of the two adjacent glutamine residues was the target of enzymatic modification. Boc-QIV showed no substrate activity with either enzyme. Crosslinking of crystallins in Ca2+-treated rabbit lens homogenate was readily inhibited by Boc-QQIV, Boc-AQQIV, and pEAQQIV, as was the formation of a-chain polymers in human fibrin by pEAQQIV in the presence of human factor XIlla. SDS/PAGE analysis suggested that the inhibitory peptides selectively blocked the electron donor functionalities in these enzymatic crosslinking reactions.
producing a variety of fused homo-and heteropolymeric structures in biological systems (illustrated for dimerization in Scheme 1 on the next page). The kinetic pathway of catalysis by these enzymes, operating with cysteine active centers, is essentially the same as that for proteases such as chymotrypsin, trypsin, or papain, where a Michaelis-type of complexation is followed by the chemical steps of acylation and deacylation. What sets the group of transglutaminases apart from the proteases is a remarkable affinity for the electron-donating second substrate, usually a primary amine, which causes an aminolytic deacylation instead of hydrolysis by water. Unlike with proteases, there is a readily discernible additional complexation of the acylenzyme intermediate with the amine prior to deacylation. This high degree of specificity for the amine made it possible to find synthetic donors [e.g., glycine ethyl ester, N-(5-aminopentyl)-5-dimethylamino-1-naphthalenesulfonamide (dansylcadaverine) (1) ] that could compete effectively against the E-amino functionalities of lysine in the natural donor protein (marked in the schemes with an oval) that would otherwise become crosslinked to the acceptor protein (marked with a rectangle). Thus, incorporation of the alternative donor (RNH2; Scheme 2) inhibits crosslinking (Scheme 1) and also leads to the enzymedirected, site-specific labeling of the participating glutaminyl residues in the acceptor protein.
Though amine-type of inhibitors of crosslinking were introduced nearly three decades ago and have been widely used ever since for the specific labeling of the glutaminyl sites of proteins (for a review, see ref.
2) the converse approach of inhibiting crosslinking by blocking of the relevant donor protein had eluded us. However, we are now able to report success in this regard, with the synthesis of suitably small, water-soluble acceptor molecules (R'CH2CH2CONH2; Scheme 3) patterned on the N-terminal sequence of fibronectin (3). Inhibition of Crystallin Crosslinking in Lens Homogenate. Frozen lenses from young rabbits (Pel-Freez Biologicals) were thawed and decapsulated, and the cortex was separated from the nucleus. The cortical portions from three lenses were homogenized by hand in 2 ml of 50 mM Tris-HCl, pH 7.5/100 mM NaCl in a Potter-Elvehjem tissue grinder. Incubations were carried out at 37°C in a total volume of 100 ,u that, in addition to homogenate (-50 mg/ml) and 20% (vol/vol) glycerol, included 0.5-4.0 mM peptide, 2 mM leupeptin (obtained through the U.S.-Japan Cooperative Cancer Research Program), and either 8 mM CaCl2 or 2 mM EDTA. The mixtures were incubated for 15 min at 37°C prior to the addition of EDTA or CaCl2, then incubated for an additional 90 min before the reaction was quenched by the addition of 20 ,l of 100 mM EDTA. The samples were centrifuged (15,600 x g for 5 min) and 10 Al of supernatant was incubated with 100 ,ul of 50 mM Tris HCI, pH 7.1/9 M urea/2% SDS/40 mM dithiothreitol for 60 min. Approximately 150 ,ug of prepared sample was analyzed by SDS/ PAGE using the discontinuous buffer system of Laemmli (8) (11) .
MATERIALS AND METHODS

RESULTS AND DISCUSSION
A previously published TLC procedure (12) was used to detect the enzyme-mediated coupling of dansylcadaverine to peptides. Fig. 1 demonstrates the factor XIIIa-catalyzed reaction of dansylcadaverine with pEAQQIV (lanes 2-4) and with Boc-AQQIV (lanes 6-8). The fluorescent coupling products of both peptides appeared in greater intensities as the reactions progressed and were well separated from the residual free dansylcadaverine, the amount of which diminished in time.
Such experiments were performed with both enzymes and the four peptides synthesized. The TLC plates were scanned [Turner, Palo Alto, CA; model 111 fluorometer; excitation wavelength, 360 nm; emission wavelength, 540 nm (13)] and by measuring peak heights of reflected fluorescence for the dansylcadaverine-labeled peptide products as well as for the unbound dansylcadaverine, the peptide-bound amine could be calculated as a fraction of the sum of the two. Figs. 2 and 3 illustrate the substrate qualities of the peptides for factor XIIIa and for transglutaminase. Interestingly, the relative order of affinities appears to be quite different for the two enzymes. With factor XIIIa, the largest peptide, pEAQQIV, was the best (Fig. 2) ; with transglutaminase, however, Boc- QQIV was the preferred substrate, and pEAQQIV itself was even less effective than Boc-AQQIV (Fig. 3) . Half-saturating concentrations for transglutaminase could be achieved with 0.1-0.2 mM Boc-QQIV or Boc-AQQIV, whereas nearly an order greater concentration of pEAQQIV was required to obtain the same for factor XIIIa. Coupling of dansylcadaverine to Boc-QQIV could also be monitored by HPLC after the transglutaminase reaction was quenched with EDTA (Beckman Ultrasphere octyl column, 4.6 x 250 mm; isocratic elution with 80% acetonitrile in 0.1% TFA; flow rate, 1.5 ml/min). With fluorescence detection, the labeled tetrapeptide emerged at about 2.76 min and free dansylcadaverine at 5.05 min.
The finding that neither enzyme could utilize Boc-QIV (Figs. 2 and 3) suggested that, of the two adjacent glutaminyl residues in the reactive peptides, the one closer to the N terminus served as the susceptible target site. Though this would accord with the observations reported for the mode of incorporation of putrescine into fibronectin itself by factor XIIIa (14) , it was still necessary to prove the point by sequencing a dansylcadaverine-substituted synthetic peptide Factor XIIIa-catalyzed coupling of dansylcadaverine to peptides. Incubations were carried out using the four peptides as described in Fig. 1 . The TLC plates were scanned as described in the text and the peptide-bound amine (ordinate) was calculated as a fraction of the total. substrate. We attached dansylcadaverine to pEAQQIV by factor XIIIa and also by transglutaminase under reaction conditions similar to those described for Figs. 2 and 3 . The dansylcadaverine-labeled hexapeptide was purified by HPLC (Beckman Ultrasphere ODS column, 4.6 x 250 mm; 30% acetonitrile in 0.1% TFA; flow rate 1.5 ml/min) and was eluted at about 6.7 min. This material was dried and was treated with pyroglutamyl aminopeptidase (EC 3.4.19.3; Boehringer Mannheim, 2.5 pg per 100 ,ul of sample in 0.1 M sodium phosphate, pH 8/10 mM dithiothreitol/5% glycerol) for 6 hr at 50°C. The deblocked, dansylcadaverine-labeled peptide was purified by HPLC as before (but now eluted at -8 min) and was sequenced (Applied Biosystems 477A protein sequencer). The factor XIIIa and the transglutaminase products gave similar results. No usual amino acid was obtained in the second sequencing cycle, but a clear sequence of AXQIV was established. We take this to mean that the derivative removed in the second cycle in sequencing the pyroglutamate-deblocked material represents the glutaminyl residue with the dansylcadaverine substitution. Next we examined whether the peptides displaying good acceptor substrate qualities toward transglutaminase (i.e., Boc-QQIV, Boc-AQQIV, and pEAQQIV) would inhibit some of the biological reactions catalyzed by these enzymes, together with the simultaneous blocking of participating donors according to the outlines of Scheme 3 presented in the Introduction. Results with the two test systems described below clearly indicate that inhibition of crosslinking and enzymatic attachment of the synthetic peptides to donor functionalities go hand-in-hand.
Inhibition of intracellular transglutaminase was assessed with the use of rabbit lens homogenate where, following the admixture of Ca2+, formation of the -55-kDa 83-crystallin dimers (designated Xf32 in Fig. 4 ) is a sensitive index of the crosslinking activity of the intrinsic enzyme (15) (16) (17) . The potencies of the peptides in blocking the formation of the Xf32 crosslinked product diminished in the order predicted from the results of Fig. 3; i.e., Boc-QQIV > Boc-AQQIV > pEAQQIV. As little as 0.5 mM Boc-QQIV caused a significant reduction of XP2 (Fig. 4, lane 3) . Examination of the SDS/PAGE profile also allowed identification of the crystallin subunits (-32 kDa, arrow in Fig. 4 2) or 0.5 mM (lanes 3, 7, and 11), 1 mM (lanes 4, 8, and 12) or 4 mM (lanes 5, 6, 9, 10, 13, and 14) Boc-QQIV (lanes 3-6), Boc-AQQIV (lanes 7-10), or pEAQQIV (lanes [11] [12] [13] [14] and either EDTA (lanes 1, 6, 10, and 14) or CaC12 (lanes 2-5, 7-9, and 11-13).
dansylcadaverine (16) , which were found to be different from those discussed here. Another remarkable feature of the experiments presented in Fig. 4 was the obvious covalent attachment of inhibitory peptides to the donor crystallin subunits under the influence of transglutaminase, i.e., requiring Ca2 . As the intensity of the -32-kDa donor band diminished with increasing concentrations of substitute acceptors added, unique bands of somewhat larger molecular size appeared in the zone designated as "peptide-decorated crystallins" (Fig. 4) . The intensities and upward displacement of such bands increased with higher peptide concentrations; they clearly represent single and multiple peptide substitutions into the donor protein.
Since pEAQQIV was the best of the synthetic acceptors for human factor XIIIa (Fig. 2) , this hexapeptide was chosen to test inhibition of the crosslinking of human fibrin by this enzyme. Fig. 5 shows the reduced chain patterns for fibrin exposed to factor XIIIa for various times. In the absence of added peptide (Fig. SA) , the disappearance of monomeric y chains and production of y-vy' dimers is followed by a depletion of monomeric a chains, with formation of an polymers, which is essentially completed by 60 min. The latter crosslinking event could be prevented with 10 mM hexapeptide (Fig. 5B) . At the same time, the position of peptide-substituted a chains shifted upwards (asterisk) in a manner quite analogous to that observed with the peptidedecorated donor crystallin subunits, as illustrated in Fig. 4 .
The success with blocking donors in a transglutaminase-or factor XIIIa-directed manner has prompted us to prepare acceptor derivatives that would carry some readily recognizable tracer, such as dansyl or biotin. Just as dansylcadaverine had many uses for labeling -glutaminyl crosslinking sites (18), a dansyl-containing synthetic acceptor probe, for example, would greatly aid in identifying the E-lysine- donating partner in heterologous crosslinking reactions and in exploring the sequence around the labeled donor residue.
